Literature DB >> 17584482

Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass.

Jinping Liu1, Bingyang Ji, Cun Long, Chunhua Li, Zhengyi Feng.   

Abstract

Studies have demonstrated that systemic inflammatory response syndrome (SIRS) remains one of the major causes of cardiopulmonary bypass (CPB)-associated organ injury during pediatric cardiac surgery. The purpose of this investigation was to compare the effectiveness of methylprednisolone (MP) and zero-balance ultrafiltration (ZBUF) on SIRS during pediatric CPB. Thirty infants undergoing open-heart surgeries were randomized to receive either MP in the priming solution (group M, n = 15) or ZBUF during CPB (group Z, n = 15). All the patients survived. Plasma levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10) were measured before CPB (T1), 5 min after the start of CPB (T2), at the termination of CPB (T3), the fourth hour (T4), and the eighth hour (T5) postoperatively. The results showed that the plasma concentrations of TNF-alpha in the Z group were significantly less than those in the M group at T4 and T5 (P < 0.05), and the plasma concentrations of IL-6 were significantly less than those in the M group at T4 (P < 0.05); the plasma concentrations of IL-8 in the Z group were significantly less than those in the M group at T5 (P < 0.05). There was no difference between two groups on the plasma concentrations of IL-10. The duration of postoperative mechanical ventilation was (9.6 +/- 0.8 h) in the M group and (7.8 +/- 0.4 h) in the Z group (P < 0.05). This study showed that application of ZBUF is more effective to decrease the level of inflammatory mediators including TNF-alpha, IL-6, and IL-8 than administration of MP after pediatric CPB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584482     DOI: 10.1111/j.1525-1594.2007.00423.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  5 in total

Review 1.  WITHDRAWN: Prophylactic steroids for pediatric open heart surgery.

Authors:  Mahmoud Elbarbary; Wedad H Madani; Suzanne Robertson-Malt
Journal:  Cochrane Database Syst Rev       Date:  2015-10-21

2.  Continuous monitoring of inflammation biomarkers during simulated cardiopulmonary bypass using a microfluidic immunoassay device - a pilot study.

Authors:  Lawrence A Sasso; Kiana Aran; Yulong Guan; Akif Ündar; Jeffrey D Zahn
Journal:  Artif Organs       Date:  2013-01       Impact factor: 3.094

3.  Glucocorticoids improve calcium cycling in cardiac myocytes after cardiopulmonary bypass.

Authors:  Jeffrey M Pearl; David M Plank; Kelly M McLean; Connie J Wagner; Jodie Y Duffy
Journal:  J Surg Res       Date:  2009-06-06       Impact factor: 2.192

4.  Neurocognitive monitoring and care during pediatric cardiopulmonary bypass-current and future directions.

Authors:  Jennifer K Lee; R Blaine Easley; Kenneth M Brady
Journal:  Curr Cardiol Rev       Date:  2008-05

5.  Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass.

Authors:  Ben Gibbison; José Carlos Villalobos Lizardi; Karla Isis Avilés Martínez; Daniel P Fudulu; Miguel Angel Medina Andrade; Giordano Pérez-Gaxiola; Alvin Wl Schadenberg; Serban C Stoica; Stafford L Lightman; Gianni D Angelini; Barnaby C Reeves
Journal:  Cochrane Database Syst Rev       Date:  2020-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.